Corrigendum to 'Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study' (Br J Anaesth 2022; 129: 49-57)
1 Department of Pharmacology, Yonsei University College of Medicine, Seoul, South Korea.
2 Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
3 Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: hanesth@yuhs.ac.